Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bone Biologics CorpBBLG · Entity 8560 | Director | January 01, 2018 | March 20, 2018 |
| NEONC TECHNOLOGIES HOLDINGS, INC.NTHI · Entity 6646 | Director | March 26, 2025 | May 19, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bone Biologics Corp
Report date January 01, 2018 · Filed March 20, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Employee Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.97 · Expires 2028-01-01 | Direct | 121,442 |
Reported balance
After 2018-01-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-01-01 · Grant · Acquired 26,109 · Balance 121,442 F1: Vests in four (4) equal quarterly installments over the one year period from the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Vests in four (4) equal quarterly installments over the one year period from the date of grant.
NEONC TECHNOLOGIES HOLDINGS, INC.
Report date March 26, 2025 · Filed May 19, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 55,310 |
Ending reported balance
After 2025-05-12 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-03-26 · Purchase · Acquired 50 · Balance 50,260 F1: Represents the weighted average purchase price. The Shares were purchased at prices ranging from $17.50 to $15.14 per share, inclusive. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request. Row 2 · 2025-04-17 · Purchase · Acquired 50 · Balance 50,310 Row 3 · 2025-05-12 · Purchase · Acquired 5,000 · Balance 55,310 F2: Represents the weighted average purchase price. The Shares were purchased at prices ranging from $7.38 to $6.99 per share, inclusive. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the weighted average purchase price. The Shares were purchased at prices ranging from $17.50 to $15.14 per share, inclusive. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request.
F2: Represents the weighted average purchase price. The Shares were purchased at prices ranging from $7.38 to $6.99 per share, inclusive. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 12, 2025 Filed May 19, 2025 21:27 UTC | NEONC TECHNOLOGIES HOLDINGS, INC. NTHI · Entity 6646 | PurchaseCommon Stock | 5,000 | $7.22 | $36,110.00 |
DisclosureSEC source: 0001213900-25-045603 · marketforms-69533.xml · nonDerivative · entry 3 Delshad Jim · CIK 0001605790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,310 F2 · price: Represents the weighted average purchase price. The Shares were purchased at prices ranging from $7.38 to $6.99 per share, inclusive. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request. Read SEC document |
| April 17, 2025 Filed May 19, 2025 21:27 UTC | NEONC TECHNOLOGIES HOLDINGS, INC. NTHI · Entity 6646 | PurchaseCommon Stock | 50 | $6.92 | $346.00 |
DisclosureSEC source: 0001213900-25-045603 · marketforms-69533.xml · nonDerivative · entry 2 Delshad Jim · CIK 0001605790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,310 Read SEC document |
| March 26, 2025 Filed Mar 28, 2025 20:35 UTC | NEONC TECHNOLOGIES HOLDINGS, INC. NTHI · Entity 6646 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001013762-25-004358 · marketforms-68082.xml · nonDerivative · entry 1 Delshad Jim · CIK 0001605790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,160 F1 · shares: Grant of 50,000 shares of restricted stock (the "Shares") pursuant to Issuer's 2023 Equity Incentive Plan. The Shares vest 100% seven months after the date of grant. Read SEC document |
| March 26, 2025 Filed May 19, 2025 21:27 UTC | NEONC TECHNOLOGIES HOLDINGS, INC. NTHI · Entity 6646 | PurchaseCommon Stock | 50 | $16.05 | $802.30 |
DisclosureSEC source: 0001213900-25-045603 · marketforms-69533.xml · nonDerivative · entry 1 Delshad Jim · CIK 0001605790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,260 F1 · price: Represents the weighted average purchase price. The Shares were purchased at prices ranging from $17.50 to $15.14 per share, inclusive. Full information regarding the number of Shares sold at each price shall be provided to the Securities and Exchange Commission staff, Issuer or any security holder, upon request. Read SEC document |
| January 01, 2018 Filed Mar 20, 2018 20:12 UTC | Bone Biologics Corp BBLG · Entity 8560 | GrantNon-Employee Stock Option · Derivative | 26,109 | $0.00 Strike: $1.97 | $0.00 |
DisclosureSEC source: 0001493152-18-003652 · form4.xml · derivative · entry 1 Delshad Jim · CIK 0001605790 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,442 Underlying: Common Stock · 26,109 shares Expires 2028-01-01 F1 · derivative.exercise_date: Vests in four (4) equal quarterly installments over the one year period from the date of grant. Read SEC document |
| January 01, 2017 Filed Apr 21, 2017 20:53 UTC | Bone Biologics Corp BBLG · Entity 8560 | GrantNon-Employee Stock Option · Derivative | 26,780 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001493152-17-004282 · form4.xml · derivative · entry 1 Delshad Jim · CIK 0001605790 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,333 Underlying: Common Stock · 26,780 shares Expires 2027-01-01 F1 · derivative.exercise_date: Vests in four (4) successive equal quarterly installments over the one-year period measured from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.